ENDRA Life Sciences Inc

Research ENDRA Life Sciences Inc (NDRA) on Bullrun: market cap USD 8.78M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 8.78M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 0-USD 7.03M-USD 5.20Mn/a-8.93USD 762.37KUSD 492.35KUSD 2.26M
FY2024USD 0-USD 11.51M-USD 7.42Mn/a-56.94USD 3.23MUSD 0USD 2.56M
FY2023n/a-USD 10.06M-USD 9.58Mn/a-2766.85USD 2.83MUSD 28.48KUSD 5.66M
FY2022n/a-USD 13.18M-USD 12.97Mn/an/aUSD 4.89MUSD 28.48KUSD 7.20M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 8.78Mn/an/an/a
20252025-12-31USD 5.33Mn/an/an/a
20242024-12-31USD 3.36Mn/an/an/a
20232023-12-29USD 17.81Mn/an/an/a
20222022-12-30USD 12.82Mn/an/an/a
20212021-12-31USD 31.49Mn/an/an/a

About ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion...

Related stock research

Other Healthcare stocks

Frequently asked questions

What is ENDRA Life Sciences Inc's market cap?

ENDRA Life Sciences Inc's market capitalization is USD 8.78M.

What does ENDRA Life Sciences Inc do?

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc.